Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcombank reported for the 3 months of 2025 by IFRS

5/16/25 SVCB

HeadHunter reported for 3 months of 2025 by IFRS

5/16/25 HEAD

PhosAgro reports for 3 months of 2025 by IFRS

5/15/25 PHOR

PhosAgro sales in Q1 up 6.8%

5/15/25 PHOR

Board of Directors of Phosagro recommended that dividends be paid for 3 months 2025

5/15/25 PHOR

Rentifly attracts investment

5/15/25 OTCI

Etalon enters Khabarovsk region

5/15/25 ETLN

Shareholders of LUKOIL approved dividends for 2024

5/15/25 LKOH

Unipro reported for 3 months of 2025 by RAS

5/15/25 UPRO

APRI maximizes the profitability of the Fanpark and Attraction projects

5/15/25 APRI